SCOPUS 정보 검색 플랫폼

Lung India

Volumn 29, Issue 1, 2012, Pages 95-96

Ethics, human rights and programmatic management of drug-resistant tuberculosis

(1) Dholakia, Yatin N a

a Maharashtra State Anti Tuberculosis Association (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; KANAMYCIN; OFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; STREPTOMYCIN;

ACID FAST BACTERIUM; BACTERIAL STRAIN; DRUG SENSITIVITY; EPIDEMIC; FOLLOW UP; HUMAN; HUMAN RIGHTS; INDIA; LETTER; MEDICAL ETHICS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATIENT CARE; PERU; PUBLIC HEALTH SERVICE; SHORT COURSE THERAPY; SPUTUM CULTURE; WORLD HEALTH ORGANIZATION;

EID: 84856610835 PISSN: 09702113 EISSN: 0974598X Source Type: Journal
DOI: 10.4103/0970-2113.92384 Document Type: Letter

Times cited : (1)

References (8)

1
- 80054049220
- Status Report on RNTCP
- Kumar A. Status Report on RNTCP. Indian J Tuberc 2011;58:132-5.
- (2011) Indian J Tuberc , vol.58 , pp. 132-5
- Kumar, A.¹

2
- 69149108538
- DOTS plus for multi-drug resistant tuberculosis in India: Early results after three years
- Arora VK, Sarin R, Singla R, Khalid UK, Mathuria K, Singla N, et al. DOTS plus for multi-drug resistant tuberculosis in India: Early results after three years. Indian J Chest Dis Allied Sci 2007;49:75-80.
- (2007) Indian J Chest Dis Allied Sci , vol.49 , pp. 75-80
- Arora, V.K.¹ Sarin, R.² Singla, R.³ Khalid, U.K.⁴ Mathuria, K.⁵ Singla, N.⁶

3
- 36849036943
- Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now
- Mitnick CD, Castro KG, Harrington M, Sacks LV, Burman W. Randomized Trials to Optimize Treatment of Multidrug-Resistant Tuberculosis: The time for action is now. PLoS Med 2007;4:e292.
- (2007) PLoS Med , vol.4
- Mitnick, C.D.¹ Castro, K.G.² Harrington, M.³ Sacks, L.V.⁴ Burman, W.⁵

4
- 70349141401
- Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis
- Johnston JC, Sahidi NC, Sadatsafavi M, Fitzgerald JM. Treatment outcomes of multidrug-resistant tuberculosis: A systematic review and meta-analysis. PLoS One 2009;4:e6914.
- (2009) PLoS One , vol.4
- Johnston, J.C.¹ Sahidi, N.C.² Sadatsafavi, M.³ Fitzgerald, J.M.⁴

5
- 33746403770
- Cost-effectiveness 95 of treating multidrug-resistant tuberculosis
- Resch SC, Salomon JA, Murray M, Weinstein MC. Cost-effectiveness 95 of treating multidrug-resistant tuberculosis. PLoS Med 2006;3:e241.
- (2006) PLoS Med , vol.3
- Resch, S.C.¹ Salomon, J.A.² Murray, M.³ Weinstein, M.C.⁴

6
- 68449087763
- High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India
- D'souza DT, Mistry NF, Vira TS, Dholakia Y, Hoffner S, Pasvol G, et al. High levels of multidrug resistant tuberculosis in new and treatment-failure patients from the Revised National Tuberculosis Control Programme in an urban metropolis (Mumbai) in Western India. BMC Public Health 2009;9:211.
- (2009) BMC Public Health , vol.9 , pp. 211
- D'Souza, D.T.¹ Mistry, N.F.² Vira, T.S.³ Dholakia, Y.⁴ Hoffner, S.⁵ Pasvol, G.⁶

7
- 77956254920
- RNTCP and tuberculosis control - High time to act
- Jain NK. RNTCP and tuberculosis control - High time to act. Lung India 2010;27:108-10.
- (2010) Lung India , vol.27 , pp. 108-10
- Jain, N.K.¹

8
- 80052552503
- st century: Back to the basics
- st century: Back to the basics. Lung India 2011;28:193-200.
- (2011) Lung India , vol.28 , pp. 193-200
- Joshi, J.M.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.